CV Sciences (CVSI) Consolidated Net Income (2011 - 2026)
CV Sciences (CVSI) posted Consolidated Net Income of -$643000.0 for Q1 2026, down 499.38% sequentially from $161000.0 in Q4 2025, and down 489.91% YoY from $164910.6 in Q1 2025.
CV Sciences (CVSI) Consolidated Net Income (2011 - 2026) Analysis & Trends
CV Sciences has reported Consolidated Net Income for 16 years, with the latest figure at -$643000.0 in Q1 2026.
- Quarterly Consolidated Net Income fell 489.91% year-over-year to -$643000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 30.3% YoY) and the FY2025 annual result came in at -$591000.0, up 72.29% from the prior year.
- Consolidated Net Income eased to -$643000.0 in Q1 2026 per CVSI's latest filing, from $161000.0 in the prior quarter.
- Over five years, Consolidated Net Income peaked at $5.7 million in Q1 2023 and troughed at -$2.7 million in Q2 2022.
- A 5-year average of -$394294.1 and a median of -$584000.0 in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2023: Consolidated Net Income tumbled 2477.5% in 2022, then soared 369.79% in 2023.
- Over 5 years, Consolidated Net Income stood at -$625000.0 in 2022, then plunged by 41.28% to -$883000.0 in 2023, then jumped by 47.34% to -$465000.0 in 2024, then surged by 134.62% to $161000.0 in 2025, then plunged by 499.38% to -$643000.0 in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$643000.0, $161000.0, and -$382000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.12 Mn | 3.86 Mn | 1.45 Mn | -775,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -775,000.00 |
| Mar 31, 2026 | -643,000.00 |
| Dec 31, 2025 | 161,000.00 |
| Sep 30, 2025 | -382,000.00 |
| Jun 30, 2025 | -261,000.00 |
| Mar 31, 2025 | -109,000.00 |
| Dec 31, 2024 | -465,000.00 |
| Sep 30, 2024 | -456,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Mar 31, 2024 | -628,000.00 |
| Dec 31, 2023 | -883,000.00 |
| Sep 30, 2023 | -447,000.00 |
| Jun 30, 2023 | -1.29 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | -625,000.00 |
| Sep 30, 2022 | -1.03 Mn |
| Jun 30, 2022 | -2.65 Mn |
| Mar 31, 2022 | -2.12 Mn |
| Dec 31, 2021 | -8.86 Mn |
| Sep 30, 2021 | -40,000.00 |